Position in ENOV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,642,211
+$5,954,526 QoQ
Shares Held
369,189
+397.7% QoQ
Ownership
0.640%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 253 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Amundi holds $3,367,612,014 across 33 Medical Devices names. ENOV ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
8,906,252 | $808,153,301 | |
| 2 | BSX |
Boston Scientific Corp
|
14,296,121 | $610,158,441 | |
| 3 | MDT |
Medtronic plc
|
5,824,040 | $455,614,643 | |
| 4 | SYK |
Stryker Corp
|
1,246,353 | $392,401,775 | |
| 5 | DXCM |
Dexcom Inc
|
5,603,490 | $377,395,050 | |
| 6 | EW |
Edwards Lifesciences Corp
|
2,579,748 | $233,363,999 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
2,500,094 | $160,031,015 | |
| 8 | STE |
STERIS plc
|
513,373 | $108,100,950 |
All Filings in ENOV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,642,211 | 369,189 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,687,685 | 74,184 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,931,586 | 72,507 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $297,392 | 9,802 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $307,390 | 9,802 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,528 | 40 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,755 | 40 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $885,946 | 13,817 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||